Safety and immunogenicity of ChAdOx1 nCoV-19 (AZD1222) vaccine in adults in Kenya: a phase 1/2 single-blind, randomised controlled trial.Hamaluba M
Sang S
Orindi B
Njau I
Karanja H
Kamau N
Gitonga JN
Mugo D
Wright D
Nyagwange J
Kutima B
Omuoyo D
Mwatasa M
Ngetsa C
Agoti C
Cheruiyot S
Nyaguara A
Munene M
Mturi N
Oloo E
Ochola-Oyier L
Mumba N
Mauncho C
Namayi R
Davies A
Tsofa B
Nduati EW
Aliyan N
Kasera K
Etyang A
Boyd A
Hill A
Gilbert S
Douglas A
Pollard A
Bejon P
Lambe T
Warimwe G
COVVaccine Trial Group
Wellcome Open Res, (2023). 8:182
Epidemiology of COVID-19 infections on routine polymerase chain reaction (PCR) and serology testing in Coastal Kenya.Nyagwange J
Ndwiga L
Muteru K
Wamae K
Tuju J
Testing Team C
Kutima B
Gitonga J
Karanja H
Mugo D
Kasera K
Amoth P
Murunga N
Babu L
Otieno E
Githinji G
Nokes DJ
Tsofa B
Orindi B
Barasa E
Warimwe G
Agoti CN
Bejon P
Ochola-Oyier LI
Wellcome Open Res, (2022). 7:69
